Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Lapatinib vs Placebo in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
2005-002485-11Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in head and neck squamous cell carcinoma (HNSCC) comparing Lapatinib with Placebo (2 arms). Primary endpoint: Tumor apoptosis/necrosis after lapatinib versus placebo. Started Oct 2005; status: completed.
02
Drugs
lapatinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2005-002485-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002485-11.